LENZ Therapeutics Inc — Quarterly Balance Sheet (NASDAQ:LENZ)

Financials

Total revenue ———5 M12.5 M — Gross profit ———5 M12.5 M — Operating expenses 12.95 M15.22 M16.93 M21.86 M31.39 M 85.4 M Selling/general/admin expenses 6.49 M9.36 M11.11 M12.8 M27.6 M 60.86 M Research & development 6.45 M5.87 M5.82 M9.06 M3.79 M 24.54 M Operating income 12.95 M15.22 M16.93 M16.86 M18.89 M 67.9 M Non-Operating Income, Total 2.73 M1.45 M2.31 M2.44 M2.19 M 8.4 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 2.72 M4.15 M2.3 M2.25 M2.17 M 10.87 M Unusual income/expense 6 000-2.7 M11 K199 K14 K -2.48 M Pretax income 15.68 M16.68 M19.24 M14.41 M16.7 M 67.03 M Equity in earnings ————— — Taxes 024.18 M0500 K0 24.68 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 10.21 M12.65 M14.62 M14.91 M16.7 M 58.88 M Discontinued operations ————— — Net income 10.21 M12.65 M14.62 M14.91 M16.7 M 58.88 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 10.21 M12.65 M14.62 M14.91 M16.7 M 58.88 M Basic earnings per share (Basic EPS) -0.381.97-0.53-0.53-0.59 0.32 Diluted earnings per share (Diluted EPS) -0.381.97-0.53-0.53-0.59 0.32 Average basic shares outstanding 27.17 M21.28 M27.53 M28.08 M28.54 M 105.43 M Diluted shares outstanding 27.17 M21.28 M27.53 M28.08 M28.54 M 105.43 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 10 K25 K36 K19 K125 K 205 K